OCEAN VIEW, Del., Oct. 18, 2017 /PRNewswire-iReach/ -- Tubeless
Insulin Pump Market is poised to surpass USD
2 billion by 2024; according to a new research report by
Global Market Insights, Inc. Rising number of diabetic and obese
patients coupled with introduction of advanced pump will serve as
high impact rendering factors for the tubeless insulin pump market
growth.
Advent of new technologies in continuous glucose monitoring
without the need for daily insulin injection doses will stimulate
business growth over the forecast years. Growing adoption of
minimally invasive insulin delivery methods should improve patient
compliance.
Request for a sample of this research report @
https://www.gminsights.com/request-sample/detail/2032
Inadequate reimbursement coverage and high long-term cost
associated with tubeless insulin pump will hamper its adoption in
emerging economies. Compliance to insulin therapy may reduce owing
to high maintenance therapy cost.
The pods/patches tubeless insulin pump market should witness
more than 20% CAGR over the coming years. Regular replacement of
pods and high usage frequency will drive the escalated demand for
these products.
Tubeless insulin pump remote should grow in parallel with
the pods segment. Although the replacement rate of remotes is not
as high as that of pods, their initial capital requirement is
higher. Increasing sales of new tubeless insulin pump will fuel the
significant growth of the remote market.
Distribution of tubeless insulin pump through e-commerce
platforms has become the most popular medium. In 2016, e-commerce
held the market share of over 50%, valuing more than USD 250 million. This online platform will
witness a significant growth over the forecast period.
Distribution through hospitals is less preferred medium because
of the high cost of tubeless insulin pump. However, many private
hospitals have recently started offering tubeless insulin pump at
affordable prices, augmenting the industry growth of the tubeless
insulin pump market.
Browse key industry insights spread across 130 pages with 66
market data tables & 8 figures & charts from the report,
"Tubeless Insulin Pump Market" in detail along with the
table of contents:
https://www.gminsights.com/industry-analysis/tubeless-insulin-pump-market
U.S. tubeless insulin pump market valued over USD 200 million in 2016 and anticipated to grow
significantly over the coming years. Switching of insulin pump user
from tubed to tubeless should be the major growth rendering factor.
Moreover, increasing adoption of tubeless pump by first time users
will fuel regional industry growth.
Germany tubeless insulin pump
market accounted for more than 20% of overall regional revenue
share, owing to increasing number of diabetic patients and advanced
healthcare system. Growing adoption of advanced technology will
drive rapid industry grow over the forecast years.
Japan tubeless insulin pump
market accounted for largest regional revenue share owing to its
growing trend to adopt advanced technology. Rising per capita
income of diabetic patients and high healthcare expenditure will
promote tubeless insulin pump market growth.
China should witness lucrative
growth in terms of revenue over the forecast period. Factors such
as economic growth, large unaddressed diabetic population, rising
disposable income, and improving healthcare facilities will propel
business growth.
Brazil tubeless insulin pump
market is projected to grow at 18% CAGR of over the forecast
period. Availability of tubeless insulin pump in recent years will
stimulate steady business expansion.
Some of the companies operating in tubeless insulin pump market
are Insulet Corporation, Johnson & Johnson, Medtrum
Technologies, Roche Holding, Cellnovo Group, Spring Health
Solution, Debiotech, CeQur, Valeritas, and Abbott Diabetes
Care.
New product launches and geographical expansion will primarily
drive the industry. Key industry participants will strive to
strengthen their position in this competitive market by adoption
these strategies.
Make an inquiry for purchasing this report @
https://www.gminsights.com/inquiry-before-buying/2032
Browse Related Reports:
Antidiabetics Market Size 2017-2024
Antidiabetics Market share was valued over USD 49.5 billion in 2016 and is expected to
witness more than 10.5% CAGR from 2017 to 2024. Growing geriatric
population along with escalating diabetes prevalence across the
globe should drive the antidiabetics market share.
https://www.gminsights.com/industry-analysis/antidiabetics-market
Insulin Delivery Devices Market Size 2017-2024
Insulin Delivery Devices Market share is expected to witness a
considerable growth over the forecast period. Increasing diabetes
prevalence will drive insulin delivery devices market growth
throughout the forecast period. As per the Centers for Disease
Control and Prevention (CDC) about over 20 million people are
stated to have diabetes.
https://www.gminsights.com/industry-analysis/insulin-delivery-devices-market
About Global Market Insights
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research
and consulting service provider; offering syndicated and custom
research reports along with growth consulting services. Our
business intelligence and industry research reports offer clients
with penetrative insights and actionable market data specially
designed and presented to aid strategic decision making. These
exhaustive reports are designed via a proprietary research
methodology and are available for key industries such as chemicals,
advanced materials, technology, renewable energy and
biotechnology.
Contact Us:
Arun
Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://www.gminsights.com/blogs
Connect with
us: Facebook | Google+ | LinkedIn | Twitter
Media Contact: Arun Hegde,
Global Market Insights, Inc., +13028467766,
sales@gminsights.com
News distributed by PR Newswire iReach:
https://ireach.prnewswire.com
SOURCE Global Market Insights, Inc.